Epicutaneous Testing of Cosmetics for Skin Compatibility
ConditionDermatitis
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorInsel Gruppe AG, University Hospital Bern
About this trial
The dermatological testing of cosmetic products which are new on the market, or existing products with novel formulations is common and a useful procedure, yet necessary to alleviate common irritants and contact allergic reactions. Cosmetic products contain a range of substances that may be considered as potential irritants or contact allergens. In order to estimate that risk, cosmetics are tested by applying patch tests.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Men and women older than 18 years old
Persons undergoing a diagnostic patch test for reason of a skin disease
Signed written informed consent
Disqualifiers
Acute skin inflammation and eczema on the back
Systemic corticosteroid and immunosuppressive therapy as well as UV exposure of the back within the last 4 weeks
Topical corticosteroids used on the back within the last two weeks
Trial design
Design model
Single group
Treatments tested in this trial
Patch test application
Other interventiontest patch with cosmetic product will be applied to the back
Treatment groups
180 Participants
are divided into 1 treatment groupGroup A: patch testExperimental treatment 1 intervention
Trial outcomes
Primary outcomes
1
Number of patients with positive patch test reactions to cosmetics
Inflammation of Skin at test patch location
Time frame
4 weeksSponsors and contacts
Click on the lead sponsor to view all of their trials.
Insel Gruppe AG, University Hospital Bern
Lead sponsor
Mibelle AG
Collaborator
Source ClinicalTrials.gov